SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.88 |
| Enterprise Value ($M) | 11.92 |
| Book Value ($M) | -1.66 |
| Book Value / Share | -0.04 |
| Price / Book | -5.95 |
| NCAV ($M) | -3.22 |
| NCAV / Share | -0.08 |
| Price / NCAV | -3.07 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.63 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.30 |
| Current Ratio | 0.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.10 |
| Assets | 2.66 |
| Liabilities | 4.32 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.55 |
| Operating Income | -0.79 |
| Net Income | -0.97 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -1.03 |
| Cash from Investing | -0.09 |
| Cash from Financing | 1.11 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| BGMD – BG Medicine, Inc. | BIEI – Premier Biomedical, Inc. |
| BIMT – Bitmis Corp. | BIXT – Bioxytran, Inc. |
| BLFE – BioLife Sciences Inc. |
Financial data and stock pages provided by
Fintel.io